| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3853013 | Diálisis y Trasplante | 2007 | 9 Pages |
Abstract
Moreover, intravenous iron sucrose is a cost-effective treatment because it reduces the required dosage of erythro-poiesis-stimulating agents. Intravenous iron sucrose is safe and well-tolerated and, therefore, represents a good choice for the treatment and prevention of iron-deficiency anemia.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Elena Donado, Marta Aguasca, Julen Ocharan-Corcuera, Iñaki Minguela, Isabel Gimeno, Alejandro Chena, Ramón Ruiz-De-Gauna,